Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education.
Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.
In this episode, Jennifer R. Brown, MD, PhD, and John Allan, MD, discuss recent key clinical trial results in Waldenström macroglobulinemia, mantle cell lymphoma, Hodgkin lymphoma, and DLBCL presented at the 2020 annual meetings of the American Society of Clinical Oncology (ASCO) and the European Hematology Association (EHA). Studies include:
Content based on an online CME program supported by an educational grant from AstraZeneca.
Link to full program: https://www.clinicaloptions.com/oncology/conference-coverage/global-asco-eha-2020
Download this slideset to review the latest clinical data informing optimal management strategies for follicular lymphoma
Download this ExpressPoints slideset for a quick summary of the latest clinical data informing optimal management of follicular lymphoma
Expert insight commentary from Clinical Care Options (CCO) on use of luspatercept for the treatment of anemia in myelodysplastic syndromes (MDS) patients
Watch a short video providing an expert view on treatment options after BTK inhibitor– and venetoclax for patients with CLL from Clinical Care Options (CCO)